The catheters are indicated for treating paroxysmal atrial fibrillation as an early rhythm control strategy.
The carotid artery bare metal stents (BMS) market experienced a 2.7% growth in revenue in the Asia-Pacific (APAC) region last year, despite the impacts of the Covid-19 pandemic.
Abbott Laboratories' new transcatheter aortic valve replacement (TAVR) system, Navitor, recently received regulatory approval in Europe.
The National Health Service England (NHS) has unveiled a new technology called HeartFlow to quickly detect and treat people with suspected heart disease.
Medtronic has received CE mark for its Evolut PRO+ TAVI System in Europe to treat patients with symptomatic severe aortic stenosis.
On April 28, 2021, Phoenix Cardiac Devices gained regulatory CE mark approval for its BACE (basal annuloplasty of the cardiac externally) device, for treatment of functional mitral regurgitation.